Newsroom

All-in-one test could fast-track care for people with possible sepsis

Inflammatix Sepsis Test Outperformed Established Biomarkers, Study Finds

Immune cell ‘signatures’ could help guide treatment for critically ill patients

TriVerity Test Demonstrates High Accuracy in Differentiating Bacterial Versus Viral Infections

FDA clears acute infection and sepsis test

Recognizing It Early While Getting It Right: The Value of Novel Sepsis Testing Tools

A better, faster sepsis test that can save lives

Inflammatix Gets FDA Clearance for 30-Minute Sepsis Test, Preps for US Launch

Inflammatix Scores FDA Approval for Precision Infection Test

Inflammatix begins trial evaluating mRNA test for patient infection status

Inflammatix Adds MedTech Veteran as First General Counsel

Inflammatix Raises $57M in Series E Financing